Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market
The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.
1 across the spectrum. Choose a side on the bar to jump to it.
1 article from 1 source. Updated Aug 19, 2026.
Left
0 sourcesNo Left coverage yet.
A blind spot on this side of the story.
Center
0 sourcesNo Center coverage yet.
A blind spot on this side of the story.
Right
1 sourceEli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market